跳至主要内容
临床试验/NCT00966888
NCT00966888Unknown3 期

Selective Use of Postoperative Radiotherapy AftEr MastectOmy - SUPREMO

Medical Research Council4 个研究点 分布在 1 个国家目标入组 3,500 人开始时间: 2006年1月最近更新:
适应症

试验速览

阶段
3 期
入组人数
3,500
试验地点
4
主要终点
Overall survival

研究概览

简要总结

RATIONALE: Radiation therapy uses high-energy x-rays or other types of radiation to kill tumor cells. Giving radiation therapy after surgery may kill any tumor cells that remain after surgery. It is not yet known whether radiation therapy is more effective than observation after mastectomy in treating women with stage II breast cancer.

PURPOSE: This randomized phase III trial is studying radiation therapy to see how well it works compared with standard therapy in treating women with stage II breast cancer who have undergone mastectomy.

详细描述

OBJECTIVES:

  • Determine the overall survival of women at intermediate risk for locoregional recurrence of breast cancer treated with ipsilateral chest wall adjuvant radiotherapy after mastectomy.

OUTLINE: This is a multicenter study. Patients are randomized to 1 of 2 treatment arms.

  • Arm I: Beginning 12 weeks after mastectomy or 6 weeks after adjuvant chemotherapy, patients undergo radiotherapy 5 days a week for 3-5 weeks in the absence of disease progression or unacceptable toxicity.
  • Arm II: Patients receive standard of care and observation only. After completion of study therapy, patients are followed up twice in the first year, and then annually for up to 10 years.

研究设计

研究类型
Interventional
分配方式
Randomized
主要目的
Treatment

入排标准

性别
Female
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Overall survival

Acute and late morbidity

次要结局

  • Chest wall recurrence
  • Regional recurrence
  • Disease-free survival
  • Metastasis-free survival
  • Cause of death (breast cancer, or intercurrent disease [cardiovascular or non-cardiovascular])
  • Quality of life
  • Cost effectiveness

研究者

申办方类型
Other Gov

研究点 (4)

Loading locations...

相似试验